SH2262265 Mamta VILL SEEHMA 455241044903, MAHENDRAGARH, 48 YEARS, Female 8882088816 0606900185265 09/05/2021 09/05/2021 19:26 10/05/2021 05:53 Final

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

Quality healthcare is a human right ICMR Registration No : SHMTLR MC-4056

TESTING LAB
Killa No 16/2,0-13, 17/2,0-18,18/1/2
Khewat / Khata No 157/216, Village Begampur Khatola,
Gurugram,
Haryana, India

Patient ID: SH2262265 Sample ID: 0606900185265


Name: MAMTA Sample Collected: 09/05/2021
Address: VILL SEEHMA 455241044903,MAHENDRAGARH, Sample Received: 09/05/2021 19:26
Age: 48 YEARS, Gender: FEMALE Report Generated: 10/05/2021 05:53
Mobile Number: 8882088816 Report Status: FINAL

TEST REPORT

Test Method SARS CoV-2 Qualitative RT PCR

Specimen Type Nasopharyngeal and Oropharyngeal

Gene 1: ORF1ab NA

Gene 2: N NA

Result Negative

INTERPRETATION

RESULT REMARKS

Positive RNA Specific To SARS-COV-2 Detected

Negative RNA Specific To SARS-COV-2 Not Detected

Inconclusive A Repeat Sample Is Suggested In Case Of Clinical Suspicion

Non Diagnostic Internal control not detected, samples need to be repeated

ABOUT SARS COV 2 LIMITATIONS


SARSCoV2, formerly known as 2019nCoV, is the causative agent of the coronavirus 1. Negative results do not preclude COVID19 and should not be used as the sole basis
disease 2019 (COVID19). Main symptoms of the disease include fever, cough and for patient management decisions. Negative results must be combined with clinical
shortness of breath. The virus is spread via persontoperson contact through observations, patient history, and epidemiological information.
respiratory droplets produced when a person coughs or sneezes. The SARSCoV2 2. Positive results but do not rule out bacterial infection or coinfection with other
RNA is generally detectable in nasopharyngeal/oropharyngeal swabs during the viruses.
acute phase of infection. Positive results are indicative of active infection. Real 3. Optimum specimen types and timing for peak viral levels during infections caused
Time PCR assay targets specific genes and can be used for diagnosis of SARSCoV2 by 2019nCoV have not been determined. Collection of multiple specimens (types and
virus infection which contributes to severe upper respiratory distress, complications time points) from the same patient may be necessary to detect the virus.
4. If the virus mutates in the rRTPCR target region, 2019nCoV may not be detected or
may be detected less predictably. Inhibitors or other types of interference may
produce a false negative result.
5. The performance of this test has not been established for monitoring treatment of
2019nCoV infection.

Dr. Sadia Khan Dr. Isha Rastogi


MBBS, MD-Microbiology MBBS, MD-Microbiology
Lab Director Consultant Microbiologist

REFERENCES
1. Laboratory testing for coronavirus disease 2019 (COVID19) in suspected human cases. Interim guidance. World Health Organization.
2. Druce et al. JCM. 2011
3. N. Engl. J. Med. 2020, 382, 929–936

*DISCLAIMERS
1. This is only a professional opinion. Not for Medico legal purpose.
2. Please correlate clinically.

SPICE HEALTHCARE PRIVATE LIMITED


Corporate Office: 320, Udyog Vihar - 4, Gurgaon, Haryana | CIN: U33100DL2018PTC333650
Telephone No.: +91-124-4967000 | Website: www.spicehealth.com | Email ID: customercare@spicehealth.com

------------------------- End of Report -------------------------

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy